Health Tech American Diabetes Association launches 3-year alliance to reduce amputations By Katie Adams
Patient Engagement, Hospitals American Diabetes Association acquires quality improvement organization By Mark Taylor
BioPharma, Pharma Biosimilar Insulins Promise Patients New Choices, But Competition Is Still Lacking By Frank Vinluan
MedCity Influencers, Devices & Diagnostics America’s Silent Liver Crisis: Are We Ready To Confront the Alarming Surge? By Jon Gingrich
Devices & Diagnostics Abbott-Bigfoot Deal Proves That Diabetes Is a Hot Area for Digital Health Investment By Katie Adams
MedCity Influencers Prioritizing SDOH for Patients Living with Chronic Diseases: Compassion, Coordination and Community By Javier La Fontaine and Gary Rothenberg
Consumer / Employer, Health Tech Amazon’s Automatic Coupons for Diabetes Products While “Incremental” Will Still Be a “Gamechanger,” Experts Say By Marissa Plescia
BioPharma, Pharma Novo Nordisk Aims to Succeed Where Sanofi Faltered Drugging a Weight-Loss Target By Frank Vinluan
BioPharma, Pharma A Startup Wins the First FDA Approval of a Cell Therapy for Type 1 Diabetes By Frank Vinluan
BioPharma, Pharma Eli Lilly’s Triple Mechanism Sets New High Mark for Weight Loss Drugs By Frank Vinluan